ValuationViz

ADPT fund manager activity

Adaptive Biotechnologies Corporation · Nasdaq. Reported by 6 tracked fund managers in their 13F filings, Q2 2019 to Q2 2026.

Q2 2024

ManagerActivitySharesValue% of portfolioFiled
Viking Global InvestorsNo change29,993,708$108,577,2230.42%Aug 14, 2024

Q1 2024

ManagerActivitySharesValue% of portfolioFiled
Viking Global InvestorsNo change29,993,708$96,279,8030.36%May 15, 2024

Newer quarters · Older quarters